bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
6.15
-0.42 (-6.33%)
At close: Oct 1, 2026, 4:00 PM EDT
6.01
-0.13 (-2.20%)
Pre-market: Oct 2, 2026, 8:41 AM EDT
bioAffinity Technologies Market Cap
bioAffinity Technologies has a market cap or net worth of $3.32 million as of October 1, 2026. Its market cap has decreased by -63.74% in one year.
Market Cap
3.32M
Enterprise Value
2.32M
1-Year Change
-63.74%
Ranking
Category
Stock Price
$6.15
ChartMarket Cap Chart
Since the IPO on September 1, 2022, bioAffinity Technologies's market cap has decreased from $45.03M to $3.32M, a decrease of -92.63%. That is a compound annual growth rate of -47.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 3.32M | -37.41% |
| Dec 31, 2025 | 5.30M | -62.62% |
| Dec 31, 2024 | 14.18M | 1.49% |
| Dec 29, 2023 | 13.97M | 4.34% |
| Dec 30, 2022 | 13.39M | -70.26% |
| Sep 1, 2022 | 45.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biodesix | 314.74M |
| Exagen | 196.95M |
| Burning Rock Biotech | 185.93M |
| Insight Molecular Diagnostics | 117.48M |
| Quantum Cyber | 110.13M |
| MDxHealth | 55.78M |
| Precipio | 42.39M |
| Advanced Biomed | 10.29M |